Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 257 Carcinoma, Intraductal, Noninfiltrating 24 Breast Carcinoma In Situ 21 Neoplasms 12 Neoplasm Metastasis 12 Breast Neoplasms, Male 12 Ovarian Neoplasms 10 Inflammatory Breast Neoplasms 7 Glioblastoma 6 Prostatic Neoplasms 5 Endometrial Neoplasms 5 Central Nervous System Neoplasms 5 Gliosarcoma 4 Fallopian Tube Neoplasms 4 Breast Cancer Female 4 Brain Neoplasms 4 Glioma 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Ductal, Breast 3 Breast Diseases 3 Astrocytoma 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Sarcoma 2 Recurrence 2 Pancreatic Neoplasms 2 Oligodendroglioma 2 Medulloblastoma 2 Liver Neoplasms 2 Infertility 2

Interventions

Counseling 4 Psychiatric Rehabilitation 3 Sildenafil Citrate 2 methyl N-acetylsibirosaminide 1 exemestane 1 black cohosh root extract 1 Testosterone Propionate 1 Testosterone 1 Tamoxifen 1 Surveys and Questionnaires 1 Sexual Health 1 Radiotherapy 1 Prostatectomy 1 Pilocarpine 1 Phentolamine 1 Papaverine 1 Oncology Nursing 1 Educational Status 1 Diet Therapy 1 Aromatase Inhibitors 1 Arginine 1 ArginMax 1 Alprostadil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Sexuality × Tamoxifen × Clear all

NCT02467686 2017-03-20

Cimicifuga

Irmandade da Santa Casa de Misericordia de Sao Paulo

Phase 4 Unknown

Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon ⚡